Phosphate-binding effects of sucralfate in patients with chronic renal failure.

[1]  J. Delmez,et al.  Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. , 1986, The New England journal of medicine.

[2]  J. Dobbie,et al.  Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia. , 1983, British medical journal.

[3]  R. Sherman,et al.  Reduction in serum phosphorus due to sucralfate. , 1983, The American journal of gastroenterology.

[4]  J. O'hare,et al.  Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate. , 1982, The New England journal of medicine.

[5]  R. Nagashima,et al.  Plasma Aluminum levels of patients on long term sucralfate therapy. , 1982, Research communications in chemical pathology and pharmacology.

[6]  T. Feest,et al.  FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY An Epidemiological Survey , 1979, The Lancet.

[7]  W. D. Kaehny,et al.  The dialysis encephalopathy syndrome. Possible aluminum intoxication. , 1976, The New England journal of medicine.

[8]  I. Huq,et al.  Letters to the EditorAMPICILLIN-RESISTANT SHIGA BACILLUS IN BANGLADESH , 1974 .

[9]  G. Berlyne,et al.  Hyperaluminaemia from aluminum resins in renal failure. , 1970, Lancet.

[10]  A. Alfrey,et al.  Hypermagnesemia after renal homotransplantation. , 1970, Annals of internal medicine.

[11]  C. Rich,et al.  The absorption of calcium carbonate. , 1967, Annals of internal medicine.

[12]  E. Rossmeisl,et al.  HYPERMAGNESEMIA IN RENAL FAILURE. ETIOLOGY AND TOXIC MANIFESTATIONS. , 1964, Annals of internal medicine.

[13]  G. Kazantzis,et al.  Pulmonary Fibrosis and Encephalopathy Associated with the Inhalation of Aluminium Dust , 1962, British journal of industrial medicine.

[14]  C. Dent,et al.  The treatment of renal-glomerular osteodystrophy. , 1961, The Quarterly journal of medicine.

[15]  S. Stanbury,et al.  Elective subtotal parathyroidectomy for renal hyperparathyroidism. , 1960, Lancet.